• NewcelX priced a private placement that includes one series of warrants to buy 347,134 common shares at an exercise price of $4.44.
• The warrants were issued alongside 347,134 common shares sold at $4.03 per share; the deal is expected to close around Aug. 14.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NLS Pharmaceutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-083664), on July 31, 2026, and is solely responsible for the information contained therein.